A meta-analysis of 17 studies on the impact of estrogen receptor (ER) expression on the prognosis of ovarian cancer showed that higher expression of ERα and ERβ is linked to better survival in ovarian cancer. The gene discussed is ESR2; the disease is ovarian carcinoma.